Skip to search formSkip to main contentSkip to account menu

ANTI-INHIBITOR COAGULANT COMPLEX

Known as: coagulation factor IX, II, VII and X in combination, Factor VIII bypassing fraction, Factor VIII inhibitor bypassing activity 
A sterile, freeze dried fraction of human plasma containing factor VIII coagulant antigen and both the inactive and active forms of coagulation… 
National Institutes of Health

Related topics

Related topics

10 relations
ANTI-INHIBITOR COAGULANT COMPLEX 1 UNT InjectionDrug AllergyEnzyme Activators [MoA]Reversed Anticoagulation Activity [PE]

Narrower (2)

ANTI-INHIBITOR COAGULANT COMPLEX 1 UNT Injection [Feiba]Feiba

Broader (2)

Blood Coagulation FactorCoagulants

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Optimisation d’extraction par sonication d’un coagulant naturel : mucilage des raquettes de Figuier de Barbarie.
2010
2010
The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleedings in patients with haemophilia A with an inhibitor to Factor VIII
A double blind study was carried out on 15 haemophilia A patients with inhibitors using FEIBA (Immuno) as the investigational… 
Review
2010
Review
2010
Bypassing Shame and Conversion Disorder
Abstract We report a case of conversion disorder (partial aphonia) that was successfully treated with speech therapy. During the… 
1988
1988
Procede de traitement d'epuration des eaux, avec phase de coagulation prolongee
Le procede a trait a la floculation d'eaux de surface ou d'eaux usees, avant la decantation/filtration par injection de coagulant… 
1985
1985
[The successful use of FEIBA for treatment of intracranial hemorrhage in a patient of hemophilia B with inhibitor].
1982
1982
[Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].
1981
1981
Inhibitor 保有血友病患者に対する FEIBA の使用経験と試験管内観察
1978
1978
Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.
Factor IX concentrates have been widely advocated in the treatment of haemophilic patients with factor VIII inhibitors. Five such… 
1977
1977
Treatment of Joint-Bleedings in Hemophiliacs with Antibodies to Factor VIII with High doses of Fraction Feiba.
Observations in 3 patients demonstrated, that joint-bleedings can be controlled with high doses of fraction FEIBA alone or in… 
1977
1977
The Clinical Application of Feiba Immuno in Factor VIII Inhibitor Patients
The aim of this report is to summarize the clinical and laboratory effect and possible side-effects arising in the use of FEIBA…